cannabis indica

Índice completo — página 54 de 77

Estudos 5.301 a 5.400 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2016. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.301 a 5.400

  1. 2016

    Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome.

    FavorávelEstudo em AnimaisImunodeficiência por TraumaCanabinoides Sintéticos AM-x
  2. 2016

    Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced Tinnitus

    InconclusivoEstudo em AnimaisZumbido
  3. 2016

    Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study.

    InconclusivoMetanáliseAVC
  4. 2016

    FAAH Gene Variation Moderates Stress Response And Symptom Severity In Patients With Posttraumatic Stress Disorder And Comorbid Alcohol Dependence

  5. 2016

    Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.

  6. 2016

    Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  7. 2016

    Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity

    InconclusivoMetanáliseObesidadeGestação
  8. 2016

    Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects

  9. 2016

    Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake

    InconclusivoEnsaio Clínico Duplo-CegoCanabigerol (CBG)Canabinol (CBN)+1
  10. 2016

    From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

    FavorávelMetanáliseEpilepsia
  11. 2016

    Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC.

    DesfavorávelEstudo em AnimaisDorDoenças NeurodegenerativasDor — Polineuropatia Inflamatória+3
  12. 2016

    Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids.

  13. 2016

    Geraniol Improves Endothelial Function by Inhibiting NOX-2 Derived Oxidative Stress in High Fat Diet Fed Mice

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Estresse OxidativoHipertensão Arterial+1
  14. 2016

    Geraniol Improves the Impaired Vascular Reactivity in Diabetes and Metabolic Syndrome Through Calcium Channel Blocking Effect

    FavorávelEstudo em AnimaisDiabetesSíndrome Metabólica
  15. 2016

    Geraniol Suppresses Prostate Cancer Growth Through Down-Regulation of E2F8

    FavorávelEstudo LaboratorialCâncerCâncer — Próstata
  16. 2016

    Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica+1
  17. 2016

    GPR55 Promotes Migration And Adhesion Of Colon Cancer Cells Indicating A Role In Metastasis

    FavorávelEstudo em AnimaisCâncerCâncer — Cólon
  18. 2016

    Hair analysis and its concordance with self-report for drug users presenting in emergency department

  19. 2016

    Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão Arterial
  20. 2016

    High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana

    DesfavorávelMetanáliseRejeição de TransplanteTetraidrocanabinol (THC)
  21. 2016

    High prevalence of cannabinoid hyperemesis syndrome in marijuana users

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  22. 2016

    High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis.

  23. 2016

    Hypotension associated with ingestion of cannabinoids in two children with cancer.

  24. 2016

    Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors

    InconclusivoEstudo LaboratorialN-Araquidonoil Dopamina (NADA)
  25. 2016

    Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study

  26. 2016

    In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

    FavorávelEstudo em AnimaisCâncerCâncer — Neuroblastoma
  27. 2016

    In Vitro Assessment of Cytogenetic and Oxidative Effects of α-Pinene

    FavorávelEstudo LaboratorialEstresse Oxidativo
  28. 2016

    Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury

  29. 2016

    Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity

  30. 2016

    Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis

    FavorávelMetanálise ClínicaDorDor — CrônicaDor — Neuropatia Periférica
  31. 2016

    Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.

  32. 2016

    Integrating cannabis into clinical cancer care

    FavorávelMetanáliseDorCâncerNáusea e VômitoTHC:CBD Farmacêutico+11
  33. 2016

    Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition

    FavorávelEnsaio Clínico Duplo-CegoObesidadeSíndrome MetabólicaAnandamida (AEA)Endocanabinoide (não especificado)+3
  34. 2016

    Involvement Of Endocannabinoids In Alcohol "Binge" Drinking: Studies Of Mice With Human Fatty Acid Amide Hydrolase Genetic Variation And After CB1 Receptor Antagonists

  35. 2016

    Involvement of transient receptor potential A1 channel in algesic and analgesic actions of the organic compound limonene

    InconclusivoEstudo em AnimaisDorEstresse OxidativoDor — Nociceptiva
  36. 2016

    Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.

    FavorávelEstudo em AnimaisEpilepsiaCanabinoides Sintéticos WIN-x
  37. 2016

    Isolation and Characterization of New Cannabis Constituents from a High Potency Variety

    FavorávelEstudo LaboratorialInfecções BacterianasLeishmaniose
  38. 2016

    JWH-133, a Selective Cannabinoid CB₂ Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells

    FavorávelEstudo LaboratorialCâncerCâncer — NeuroblastomaCanabinoides Sintéticos JWH-x
  39. 2016

    Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer’s mice.

    FavorávelEstudo em AnimaisDoença de Alzheimer
  40. 2016

    Lysophosphatidylinositol Signalling and Metabolic Diseases

  41. 2016

    Marijuana Smoking in Patients With Leukemia

    DesfavorávelMetanáliseInfecções Fúngicas
  42. 2016

    Marijuana Use and Type 2 Diabetes Mellitus: a Review.

    FavorávelMetanáliseDiabetes
  43. 2016

    Marijuana use in adults admitted to a Canadian epilepsy monitoring unit.

    FavorávelMetanáliseEpilepsia
  44. 2016

    Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.

    InconclusivoMetanáliseGestação
  45. 2016

    Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team

    FavorávelEnsaio ClínicoObesidadeEndocanabinoide (não especificado)Dieta
  46. 2016

    Medical Cannabis in the Palliation of Malignant Wounds—A Case Report

    FavorávelMetanáliseCâncerCâncer — Pele (não melanoma)
  47. 2016

    Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D

    FavorávelMetanáliseDependência — Opioides
  48. 2016

    Melatonin and vitamin C exacerbate Cannabis sativa-induced testicular damage when administered separately but ameliorate it when combined in rats

    InconclusivoEstudo em AnimaisInfertilidade Masculina
  49. 2016

    Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

    DesfavorávelMetanálisePsicoseEsquizofrenia
  50. 2016

    Metabolic syndrome in people with a psychotic illness: is cannabis protective?

    FavorávelMetanáliseSíndrome Metabólica
  51. 2016

    Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence

  52. 2016

    Modulation of cellular redox homeostasis by the endocannabinoid system.

  53. 2016

    Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report

  54. 2016

    Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities

    FavorávelMetanáliseEstresse OxidativoInfecções Bacterianas
  55. 2016

    Neurobiological Interactions Between Stress and the Endocannabinoid System.

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  56. 2016

    Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+1
  57. 2016

    New therapeutic strategies for the treatment of male lower urinary tract symptoms

    FavorávelMetanáliseInfecção Urinária
  58. 2016

    Ocimum Gratissimum Essential Oil and Its Isolated Compounds (Eugenol and Myrcene) Reduce Neuropathic Pain in Mice

    FavorávelEstudo em AnimaisDorDor — Neuropatia Periférica
  59. 2016

    Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans

  60. 2016

    Opposite effects of cannabis and cocaine on performance monitoring

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — CannabisDisfunção Cognitiva+1
  61. 2016

    Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

  62. 2016

    Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaAnandamida (AEA)Palmitoiletanolamida (PEA)+3
  63. 2016

    Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+1
  64. 2016

    Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis

  65. 2016

    Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice

  66. 2016

    Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDisfunção Cognitiva+2
  67. 2016

    Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

    InconclusivoMetanáliseCaquexiaTetraidrocanabinol (THC)
  68. 2016

    Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid

  69. 2016

    Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

    FavorávelMetanáliseEsclerose MúltiplaTHC:CBD Farmacêutico
  70. 2016

    Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review

  71. 2016

    Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

  72. 2016

    Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy

    FavorávelEstudo em AnimaisCâncerCâncer — PâncreasFicocianina
  73. 2016

    Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

  74. 2016

    Phytol Has Antibacterial Property by Inducing Oxidative Stress Response in Pseudomonas Aeruginosa

    FavorávelEstudo LaboratorialEstresse OxidativoInfecções Bacterianas
  75. 2016

    Plant-Derived and Endogenous Cannabinoids in Epilepsy.

    FavorávelMetanáliseEpilepsia
  76. 2016

    Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor

  77. 2016

    Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

    FavorávelEstudo em AnimaisSíndrome do X FrágilCanabinoides Sintéticos SR-x
  78. 2016

    Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoides Sintéticos HU-x
  79. 2016

    Prenatal, perinatal, and adolescent exposure to marijuana: Relationships with aggressive behavior

    DesfavorávelMetanáliseViolência DomésticaTranstorno Explosivo Intermitente
  80. 2016

    Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers

  81. 2016

    Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251

  82. 2016

    Preventive Effect of Geraniol on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats

    FavorávelEstudo em AnimaisCâncerCâncer — Fígado
  83. 2016

    Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage.

    FavorávelMetanáliseAVC
  84. 2016

    Prohedonic Effect of Cannabidiol in a Rat Model of Depression.

    FavorávelEstudo em AnimaisDepressão
  85. 2016

    Prolonged Cardiopulmonary Bypass is a Risk Factor for Intestinal Ischaemic Damage and Endotoxaemia

  86. 2016

    Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists

  87. 2016

    Protective Effect of Geraniol on the Transgenic Drosophila Model of Parkinson's Disease

    FavorávelEstudo em AnimaisEstresse OxidativoDoença de Parkinson
  88. 2016

    Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report

    DesfavorávelMetanáliseDependência Química
  89. 2016

    Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

  90. 2016

    Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature.

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  91. 2016

    Psychosocial interventions for cannabis use disorder

    FavorávelMetanálise ClínicaDependência QuímicaDependência — Cannabis
  92. 2016

    Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States.

    DesfavorávelMetanáliseAVC
  93. 2016

    Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis

  94. 2016

    Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters

  95. 2016

    REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS

  96. 2016

    Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.

    FavorávelEnsaio ClínicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  97. 2016

    Relation between postoperative ileus and anastomotic leakage after colorectal resection: a post hoc analysis of a prospective randomized controlled trial

  98. 2016

    Repeated Thrombosis After Synthetic Cannabinoid Use.

  99. 2016

    Role of hypothalamic cannabinoid receptors in post-stroke depression in rats

    FavorávelEstudo em AnimaisDepressãoAVC
  100. 2016

    Role of the lysophosphatidylinositol/GPR55 axis in cancer

    DesfavorávelMetanáliseCâncerLisofosfatidilinositol (LPI)